Production of pro- and anti-fibrotic agents by rat kupffer cells; the effect of octreotide

Digestive Diseases and Sciences

Volumn 50, Issue 5, 2005, Pages 935-941

  Xidakis, Costas ^a   Ljumovic, Dushanka ^a   Manousou, Pinelopi ^a   Notas, George ^a   Valatas, Vassilis ^a   Kolios, George ^a   Kouroumalis, Elias ^a,b  

^a UNIVERSITY OF CRETE   (Greece)

^b UNIVERSITY HOSPITAL OF IRAKLION   (Greece)

Author keywords

Cytokines; Fibrosis; Kupffer cells; Lipopolysaccharide; Matrix metalloproteases; Octreotide

Indexed keywords

ANTIFIBRINOLYTIC AGENT; GELATINASE A; GELATINASE B; INTERSTITIAL COLLAGENASE; LEPTIN; LIPOPOLYSACCHARIDE; OCTREOTIDE; SOMATOSTATIN DERIVATIVE; TRANSFORMING GROWTH FACTOR BETA1; UROKINASE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL ISOLATION; CELL STIMULATION; CONTROLLED STUDY; DRUG EFFECT; DRUG USE; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME RELEASE; ENZYME SYNTHESIS; FIBRIN FORMATION; FIBRINOLYSIS; INCUBATION TIME; KUPFFER CELL; LIVER CELL CULTURE; LIVER CIRRHOSIS; LIVER FIBROSIS; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS; RAT; SUPERNATANT; ZYMOGRAPHY;

ANIMALS; CELL CULTURE TECHNIQUES; GASTROINTESTINAL AGENTS; KUPFFER CELLS; LEPTIN; LIPOPOLYSACCHARIDES; MALE; MATRIX METALLOPROTEINASES; OCTREOTIDE; RATS; RATS, SPRAGUE-DAWLEY; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; URINARY PLASMINOGEN ACTIVATOR;

EID: 18844436013     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-005-2668-8     Document Type: Article

References (33)

1. Arthur MJ: Degradation of matrix proteins in liver fibrosis. Pathol Res Pract 190:825-833, 1994
2. Ikejima K, Takei Y, Honda H, Hirose M, Yoshikawa M, Zhang YJ, Lang T, Fukuda T, Yamashina S, Kitamura T, Sato N: Leptin receptor-mediated signaling regulates hepatic fibrogenesis and remodeling of extracellular matrix in the rat. Gastroenterology 122:1399-1410, 2002
3. De Bleser PJ, Niki T, Rogiers V, Geerts A: Transforming growth factor-beta gene expression in normal and fibrotic rat liver. J Hepatol 26:886-893, 1997
4. Zhang LP, Takahara T, Yata Y, Furui K, Jin B, Kawada N, Watanabe A: Increased expression of plasminogen activator and plasminogen activator inhibitor during liver fibrogenesis of rats: role of stellate cells. J Hepatol 31:703-711, 1999
5. Knolle PA, Gerken G: Local control of the immune response in the liver. Immunol Rev 174:21-34, 2000
6. Bautista AP: Acute alcohol intoxication and endotoxemia desensitize HIV-1 gp120-induced CC-chemokine production by Kupffer cells. Life Sci 68:1939-1949, 2001
7. Su GL: Lipopolysaccharides in liver injury: molecular mechanisms of Kupffer cell activation. Am J Physiol Gastrointest Liver Physiol 283:G256-G265, 2002
8. Gregory SH, Wing EJ: Neutrophil-Kupffer cell interaction: a critical component of host defenses to systemic bacterial infections. J Leukoc Biol 72:239-248, 2002
9. Reichlin S: Somatostatin. N Engl J Med 309:1495-1501, 1983
10. Lamberts SW: The role of somatostatin in the regulation of anterior pituitary hormone secretion and the use of its analogs in the treatment of human pituitary tumors. Endocr Rev 9:417-136, 1988
11. Kvols LK, Buck M, Moertel CG, Schutt AJ, Rubin J, O'Connell MJ, Hahn RG: Treatment of metastatic islet cell carcinoma with a somatostatin analogue (SMS 201-995). Ann Intern Med 107:162-168, 1987
12. Farthing MJ: The role of somatostatin analogues in the treatment of refractory diarrhoea. Digestion 57(Suppl 1):107-113, 1996
13. Goulis J, Burroughs AK: Role of vasoactive drugs in the treatment of bleeding oesophageal varices. Digestion 60(Suppl 3):25-34, 1999
14. Kouroumalis E, Skordilis P, Thermos K, Vasilaki A, Moschandrea J, Manousos ON: Treatment of hepatocellular carcinoma with octreotide: a randomised controlled study. Gut 42:442-447, 1998
15. Samonakis DN, Moschandreas J, Arnaoutis T, Skordilis P, Leontidis C, Vafiades I, Kouroumalis E: Treatment of hepatocellular carcinoma with long acting somatostatin analogues. Oncol Rep 9:903-907, 2002
16. Valatas V, Kolios G, Notas G, Xidakis C, Diamantis I, Kouroumalis EA: Octreotide regulates CC but not CXC LPS-induced chemokine secretion in rat Kupffer cells. Br J Pharmacol 141:477-187, 2004
17. Valatas V, Xidakis C, Roumpaki H, Kolios G, Kouroumalis EA: Isolation of rat Kupffer cells: a combined methodology for highly purified primary cultures. Cell Biol Int 27:67-73, 2003
18. Knook DL, Sleyster EC: Separation of Kupffer and endothelial cells of the rat liver by centrifugal elutriation. Exp Cell Res 99:444-449, 1976
19. Kolios G, Valatas V, Psilopoulos D, Petraki K, Kouroumalis E: Depletion of non specific esterase activity in the colonic mucosa of patients with ulcerative colitis. Eur J Clin Invest 32:265-273, 2002
20. Leyland H, Gentry J, Arthur MJ, Benyon RC: The plasminogen-activating system in hepatic stellate cells. Hepatology 24:1172-1178, 1996
21. Benyon RC, Arthur MJ: Extracellular matrix degradation and the role of hepatic stellate cells. Semin Liver Dis 21:373-384, 2001
22. Brodsky S, Chen J, Lee A, Akassoglou K, Norman J, Goligorsky MS: Plasmin-dependent and -independent effects of plasminogen activators and inhibitor-1 on ex vivo angiogenesis. Am J Physiol Heart Circ Physiol 281:H1784-H1792, 2001
23. Fibbi G, Pucci M, Grappone C, Pellegrini G, Salzano R, Casini A, Milani S, Del Rosso M: Functions of the fibrinolytic system in human Ito cells and its control by basic fibroblast and platelet-derived growth factor. Hepatology 29:868-878, 1999
24. Okazaki I, Watanabe T, Hozawa S, Arai M, Maruyama K: Molecular mechanism of the reversibility of hepatic fibrosis: with special reference to the role of matrix metalloproteinases. J Gastroenterol Hepatol 15 (Suppl):D26-D32, 2000
25. Sakaida I, Hironaka K, Terai S, Okita K: Gadolinium chloride reverses dimethylnitrosamine (DMN)-induced rat liver fibrosis with increased matrix metalloproteinases (MMPs) of Kupffer cells. Life Sci 72:943-959, 2003
26. Melgert BN, Weert B, Schellekens H, Meijer DK, Poelstra K: The pharmacokinetic and biological activity profile of dexamethasone targeted to sinusoidal endothelial and Kupffer cells. J Drug Target 11:1-10, 2003
27. Melgert BN, Olinga P, Van Der Laan JM, Weert B, Cho J, Schuppan D, Groothuis GM, Meijer DK, Poelstra K: Targeting dexamethasone to Kupffer cells: effects on liver inflammation and fibrosis in rats. Hepatology 34:719-728, 2001
28. Hata J, Ikeda E, Uno H, Asano S: Expression of hepatocyte growth factor mRNA in rat liver cirrhosis induced by N-nitrosodimethylamine as evidenced by in situ RT-PCR. J Histochem Cytochem 50:1461-1468, 2002
29. Luckey SW, Petersen DR: Activation of Kupffer cells during the course of carbon tetrachloride-induced liver injury and fibrosis in rats. Exp Mol Pathol 71:226-240, 2001
30. Akita K, Okuno M, Enya M, Imai S, Moriwaki H, Kawada N, Suzuki Y, Kojima S: Impaired liver regeneration in mice by lipopolysaccharide via TNF-alpha/kallikrein-mediated activation of latent TGF-beta. Gastroenterology 123:352-364, 2002
31. Rivera CA, Bradford BU, Hunt KJ, Adachi Y, Schrum LW, Koop DR, Burchardt ER, Rippe RA, Thurman RG: Attenuation of CC1(4)-induced hepatic fibrosis by GdC1(3) treatment or dietary glycine. Am J Physiol Gastrointest Liver Physiol 281:G200-G207, 2001
32. Shimizu I: Antifibrogenic therapies in chronic HCV infection. Curr Drug Targets Infect Disord 1:227-240, 2001
33. De Bleser PJ, Niki T, Rogiers V, Geerts A: Transforming growth factor-beta gene expression in normal and fibrotic rat liver. J Hepatol 26:886-893, 1997